506820 Share Price Performance
₹9,324.70
1492.70 (19.06%)
Price ₹9,324.70
Share Price₹9,324.70
AstraZeneca Pharma India Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
506820 Community Narratives
There are no narratives available yet.
Recent 506820 News & Updates
AstraZeneca Pharma India Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 14, 2025
- Earnings per share (EPS)
- 73.34
- Gross Margin
- 44.27%
- Net Profit Margin
- 9.88%
- Debt/Equity Ratio
- 4.6%
AstraZeneca Pharma India Limited Competitors
Snowflake Analysis
About 506820
- Founded
- 1979
- Employees
- 802
- CEO
- WebsiteView website
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Indian Market Performance
- 7 Days: 1.5%
- 3 Months: -1.7%
- 1 Year: -4.7%
- Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. In contrast, the market has seen a decline of 4.7% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›